CDKis appears to be instrumental for maintaining human leukemia and breast cancer cells in the G0/G1 phase as was evident by the upregulation of p21/cip and p27/kip CDKi in HBA-treated cell lines in the present study. This evidence concerns the gene CIB1 and breast cancer.